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Abstract 
Understanding protein stability and the basis for why a protein folds are very 
important for the design of biological drugs for treatment of disease. Design of proteins 
has allowed researchers to discover and analyze many aspects of what it takes to make a 
protein fold and function under certain conditions, which is one of the key problems in 
biochemistry. For my project, we are working with two proteins, the DNA binding 
domain from fructose repressor (FruR or Cra), and a pheromone Er23. These proteins are 
good sources for mutation analysis because they are small and can be easily manipulated. 
This aspect will be useful for this project because our main goal is to engineer the FruR 
sequence to switch to the fold of Er23 or vice versa. We characterize these proteins using 
NMR, CD, crystallography, and fluorescence. Here we describe a successful variant of 
FruR that we created by making a mutation at position 25 from an alanine to a 
tryptophan. This tryptophan probe not only made the protein more thermodynamically 
stable by a factor of 5 °C, but will allow us to use high-throughput methods and 
fluorescence in order to observe it’s folding and unfolding much more efficiently. We 
have now turned our attention to expression of the wild type protein Er23, and 
preliminary results on expression of this pheromone will be described.  We will also 
discuss a strategy to make the smallest number of mutations necessary for Er23 to adopt 
the FruR fold. We will do this by first engineering the cysteine residues out of Er23, 
replacing them with Ala-Val mutations. This is because Ala-Val is similar to a cysteine 
pair in size and we have also had success using this type of mutation with another protein 
the lab characterizes called Rop. If we are able to completely flip the fold of Er23 into  
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FruR, this will give us knowledge of what it takes to make a protein fold and what 
conditions are needed to do so. 
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Chapter 1 
Introduction 
1.1 Protein stability 
Protein stability is one of the most complex problems in biochemistry today. The 
tertiary structure of a protein cannot currently be predicted from the primary structure. 
Two of the first people to bring this problem to the forefront of biochemistry were 
Christian Anfinsen and Cyrus Levinthal. Anfinsen made his discoveries in 1960 when he 
worked on ribonuclease which contains eight sulfhydryl groups causing many possible 
arrangements with four disulfide bonds. His main interest was in protein folding and 
finding out how the enzyme folded into its conformational structure based on its primary 
sequence. Anfinsen believed that certain interactions must guide the formation of the 
correct disulfide bonds1. He later concluded that the most stable conformation of any 
protein is the native molecule. This conformation is made stable with thermodynamics 
and correct pairing of disulfide bonds1. 
Through Levinthal’s research he was able to conclude something called the Levinthal 
Paradox. This paradox states that because there are so many possible protein 
conformations and folded states, it would be impossible to predict by exploring each and 
every fold using a computer program20. This paradox explains why protein stability and 
predicting the most stable conformation of a certain protein is so difficult.  
Other scientists have concluded that the folding of a protein can be defined as a 
funnel with an infinite number of possible outcomes and conformations ultimately 
leading to the most thermodynamically stable form. A goal of protein design is to dissect 
the balance between local and long-range interactions that stabilize a particular fold in 
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preference to the many conformational possibilities available to a given sequence. The 
results of protein conformations and folding predictions provide knowledge into how 
these forces are controlled in both protein structure and with the misfolding phenomena 4. 
Although this statement is true, we have not found a way of computationally predicting 
this most stable conformation and these findings explain why this prediction is so 
difficult to make.  
 
1.2 Computational and experimental methods 
There are two ways in which one can try to answer this complex problem which 
include computational and experimental methods. My project has included both methods 
in order to find out as much as possible about this issue. The idea of switching folds 
between two completely different proteins is a complex one which will allow us to 
discover more about their structure. Philip Bryan and John Orban have based their 
research around this computational theory and found that proteins which switch folds are 
very rare, but they provide useful information of the evolution of protein folding 2.When 
doing research with many different proteins they realized that three themes were similar 
among all flipping folds, the structural transitions are in a state with diminished stability; 
flipping fold requires the flexibility of certain areas of both proteins; there is a possibility 
of increased stability in an alternate folded state which can lead to new functions2. The 
basic conclusion of their research was that with the existence of protein sequences that 
create different folds when switching from one native structured protein to another 
provides questions for understanding how the primary amino acid sequence determines 
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structure2. Overall, it still remains a mystery which proteins can be flipped and how many 
different conformations are possible based on the primary structure. 
 Working in collaboration with Ron Elber and his lab they were able to come up 
with a computational idea in which the fold of one protein, FruR or also called Catabolite 
Activator Protein (Cra), can be flipped or switched into the fold of a completely different 
protein analytically, pheromone Er23. There are few (around 2-5) foldable sequences 
which experimentally can be flipped to a completely different fold with a minor 
modification in the sequence3. This computational analysis helps to predict protein design 
and switches from which FruR was predicted to switch to Er23 after 50 rounds of 
mutations to the sequence. To further prove this computational model we set out to 
experimentally test this in vivo and see if this switch between two different structures is 
actually possible between Er23 and FruR.  Figure 1.1 shows the structure of these two 
proteins and how similar they are to each other. 
 
 
 
 
 
 
 
 
 
Figure 1.1: The structure on the left, DNA binding domain of FruR 1HA8 and on the right pheromone 
Er23 1UXC protein shown with alpha helices blue. 
? 
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1.3: Fructose repressor protein (FruR) 
The Catabolite Activator protein, also known as Fructose 
Repressor (FruR) is an Escherichia coli transcriptional 
regulator that belongs to the LacI DNA-binding protein 
family. By using 1H and 15N NMR spectroscopy, the 
three-dimensional solution structure of the FruR N-
terminal DNA-binding domain has been determined 
consisting of 57 amino acid residues6. The DNA binding 
domain of this protein is of interest to us because it 
folds independently into a small globule which can 
easily be studied by computationally and by biophysical 
characterization. Previous work has been done on FruR by Venuka Durani25 and Eva 
Petrik including a complete Alanine scan of the protein to discover which residues of 
FruR are of particular importance for its folding into a stable conformation. 
 
 
Figure 1.2: crystal 
structure of FruR Protein 
(made in Yasara) 
Figure 1.3: E. coli 
FruR binding 
consensus sequence 
and regulatory 
region 
of the fructose 
operon of P. putida. 
(Figure from 
reference 7) 
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Figure 1.3 shows the portion of FruR which has the main function of regulating when the 
binding site is turned on or off. The N-terminal, 60 amino acid fragment of FruR is the 
DNA-binding domain, while the C-terminal 300 amino acid fragment of the protein 
remains tetrameric and displays inducer-binding properties and subunit interactions9. The 
N-terminal fragment is small and displays a helix-turn-helix motif similar to the lac-
repressor. 
 
After the protein was successfully cloned and expressed, with the method for expression 
shown in Figure 1.4 above, it was purified and then the structure was extensively 
characterized using proton NMR. They concluded that the FruR regulator is a multi-
Figure 1.4: 
Expression scheme of 
DNA-binding domain 
of Fructose Repressor 
protein taken from 
reference 9. 
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domain protein with a structural conformation similar to that of the LacI repressor 
protein9. 
Earlier studies were done on the FruR proteins in E. coli and S. typhimurium by Max 
Chavarria and Cesar Santiago where it was suggested that the regulator recognizes an 
incorrect DNA sequence and then binds to that incorrect sequence7. The crystal structures 
are shown in Figure 1.5 below. 
 
 
 
 Another study of FruR protein was done by Dayanidhi Sarkar and his lab to 
provide information about the adaptation of E. coli due to the FruR knockout gene8. Their 
studies mainly consist of doing research to find more about the metabolic pathways 
which depend greatly on carbon sources. Overall, they found that the mutants which had 
FruR knocked out of the sequence resulted in the lowest yield of activation of the 
glycolysis pathway. However, the glucose consumption rate stayed the same overall by 
their studies of this mutant8. This analysis explains the importance of FruR for the 
binding of DNA in E. coli and for activation of the glycolysis pathway. 
Figure 1.5: Crystal structure of FruR in complex with Fructose-1-Phosphate. 
(Figure taken from reference 7) 
7 
 
1.4 Pheromone Er23 
Pheromone Er23 comes from the 
protozoan Euplotes raikovi and belongs 
to a group of pheromones which are all 
purified from the same protozoa7. It is a 
protein with 51 amino acid residues and 
contains three alpha helices, similar to 
FruR. The main difference between the 
two proteins is that Er23 contains ten 
cysteine residues, making five 
disulfide bridges. This protein is also quite small which makes it easy to manipulate for 
characterization and analysis. These five disulfide bridges cause this protein to have a 
very compacted core. Er23 is unique among presently known Er-pheromones with 
respect to size and number of disulfide bonds, and the three-dimensional structure10. 
So far only the NMR structure of Er23 has been solved together with the other 
members of this pheromone family but the protein has not been characterized yet. So, this 
project will not only allow us to deduce more about the stability problem, but also will 
give us insight into the properties of Er23 and its pheromone relatives. 
Figure 1.6: NMR Structure of pheromone 
Er23 (from reference 11) 
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One study of Er23 provided NMR data of the protein shown in Figure 1.7 above and 
based on these data the structure has been solved11. 
 These pheromones are all small proteins of 38 to 51 amino acids with a common 
architecture based on a bundle of three-helices fastened together by three conserved 
disulfide bonds. It was also found that their main functions in E.coli are prototypic 
autocrine growth and paracrine mating signals12. However, because all of these 
pheromones contain disulfide bridges, including Er23, this makes expressing and 
purifying these proteins will potentially be very difficult. Because of this fact previously 
mentioned, purification was done by extraction from Euplotes raikovi12.  
 
1.5 Successful Expression and Purification of Disulfide Bond heavy proteins 
When we decided to express and purify Er23 using E. coli cells instead of 
Euplotes raikovi which we knew would be a challenge since this is something which has 
never been done previously. All previous work done on Er23 was done by extracting the 
protein from these protozoa. Therefore, we needed to design a complete expression 
strategy before we could characterize this protein. Under physiological conditions, there 
Figure 1.7: [1H, 1H]-2QF-COSY NMR of Er23 from reference 11. 
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are many reasons why expressing and purifying disulfide-heavy proteins will be 
especially difficult. For example, the E. coli cytoplasm is in a reduced state which 
disfavors the formation of stable disulfide bonds in proteins and the redox potential for 
the formation of the disulfide bonds is very low14.  This doesn’t provide a driving force 
for the formation of stable disulfides which are in active conformation. Also, there are no 
enzymes available in the cytoplasm of E. coli that can catalyze protein thiol-oxidation14.  
Because disulfide bond formation is mediated by thioredoxins, Paul Bessette and his lab 
asked if increasing the expression of these would enhance disulfide bond formation in the 
protein. Their experiments found that this was in fact true. They also found that the 
oxidation of proteins in the periplasm by DsbA may be detrimental for the folding of 
those proteins containing multiple disulfides14.  
Another study was tested in Michael Reinwarth’s lab where the question was 
asked whether oxidative folding of cysteine-knot proteins or “knottins” would be helpful 
for forming the correct disulfide bridges15. There are specific conditions needed for the 
formation of correct disulfide bonds. These may include: thiol protection, polymer-
supported oxidation, and isosteric disulfide replacements in the presence of redox-
favored species, or possibly the deletion of a disulfide bond which is not absolutely 
necessary for folding15. They found that oxidative folding of cysteine-heavy peptides is 
still very challenging because very specific folding conditions are needed to achieve the 
most stable conformation of the protein15.  
We also want to figure out more about the stabilization factors disulfide bonds 
contribute to proteins. We also wanted to deduce whether expressing and purifying 
“disulfide-heavy” proteins is difficult. They are very important for the overall stability 
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and structure of the protein in most cases. In a study done by Arnold Mcaulel and his lab 
they analyzed the effect of disulfide bonds on the stability of antibodies. They found that 
the disulfide bond could not be formed efficiently by unfolding and refolding the protein 
without use of redox reagents. In addition, it was difficult to fully reduce the disulfide 
bond using DTT without partially unfolding the protein first with guanidinium chloride. 
These observations suggested that the stable structure of folded methane is necessary to 
prevent the action of the redox agents on the hydrophobic core16.  
 
1.6 High Throughput Methods for characterization 
In order for a more quick and easy way of characterization of the mutants of both 
Er23 and FruR a high throughput method was needed in order to be as efficient as 
possible. There are many different high throughput methods which have been studied in 
Thomas Magliery’s lab including intrinsic fluorescence, H/D exchange, cysteine 
reactivity, aggregation and hydrophobic dye binding, some of which are depicted in  
Figure 1.8 below17.  
 
 Figure 1.8: Principles of screening for protein stability using high-
throughput methods. (Figure from reference 17) 
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All of these methods have positive and negative characteristics. However, 
monitoring the denatured and natured states of proteins is most easily seen using 
fluorescence by aromatic amino acid residues and this is the method we chose to use to 
monitor FruR and Er23 during our mutation analysis. This fluorescence method is useful 
because aromatic amino acid residues are fluorescent due to their conjugation containing 
many double bonds within their structures. Tryptophan gives the strongest fluorescent 
excitation over the weaker tyrosine and phenylalanine26. Once an aromatic amino acid 
was successfully introduced into the sequences of each protein while maintaining the 
native structure of the protein, this method could be successfully utilized. 
 
1.7 Constructing cysteine-free proteins  
 The main difference between Er23 and FruR is that Er23 contains five disulfide 
bridges while FruR has none. We decided to begin with sequentially removing the 
cysteines from Er23 or introducing them into FruR to eventually flip to fold of Er23 into 
FruR or vice versa. Not only did we want to remove the cysteines to start making the 
sequence of Er23 look more similar to the sequence of FruR, but also because proteins 
containing cysteine residues, especially many, are very hard to express and purify so 
removing them would make working with this protein much easier. Some previous 
studies of Cys-free proteins have been done, specifically on a well-characterized protein 
in the Magliery lab called Rop. They found that cysteine residues can complicate the 
folding and storage of proteins due to misfolding of disulfide bonds or oxidation of 
residues that are normally reduced in their native conformation18. 
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 In order to remove the cysteine residues, 
they had to be replaced with something that would 
be similar enough to allow the protein to still fold 
into its native structure. Many different mutations 
were made that were thought to be similar enough 
to a disulfide bond to preserve the native structure 
of the protein. A study was done of these mutants 
by GFP screening where the more active the GFP 
the more expression of the ColE1 plasmid where 
the expression and control of this plasmid is the main function of Rop shown above in 
Figure 1.9. They found that both the Ala/Ala and Val/Val variants were indeed active. 
However, only the Ala/Ala variant could be expressed sufficiently under the conditions 
used18. The Ala/Val mutation was the most successful of all the other variants because it 
allowed for the least destabilization of the protein and made it much easier to work with 
than the wild-type protein containing disulfide bridges18 Because this method of mutating 
out the disulfides and replacing them with Ala/Val potentially creates a protein which is 
much easier to express and manipulate we decided to use this replacement to start 
manipulating Er23. Based on these specific findings, our idea was to replace the disulfide 
bonds in Er23 to both Ala/Val and Val/Ala mutations to see which disulfide bonds (if 
any) are essential for the correct folding and the stability of Er23.  These findings will 
form the basis of the next step which is modifying the sequence of Er23 to attempt the 
fold switch between Er23 and FruR. 
 
Figure 1.9: In vivo activity of 
the cysteine variants of Rop 
from reference 18. 
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Chapter 2 
Objectives 
 
2.1 Synthesis and characterization of FruR Trp variant 
First, as previously discussed, FruR will be expressed containing a fluorescent tryptophan 
residue in order to use high-throughput methods for studying the stability effects of the 
mutations. A successful mutation will need to be made where the Trp residue is within 
the hydrophobic core while still maintaining the WT structure and stability of the protein. 
Once this has been done, it will make the screening of the states between FruR and Er23 
much easier. 
 
2.2 Synthesis and characterization of WT Er23 
To characterize and study Er23 in depth, we will need to first successfully express the 
WT Er23 protein. This will be done using previously used Origami DE3 cells containing 
the Er23-pHLIC plasmid made by Venuka Durani25 of Magliery lab. Once successfully 
expressed, we will characterize WT using CD thermal melts, NMR, and crystallography. 
 
2.3 Synthesis and characterization of Er23 Variants 
Once we have obtained more information about the wild type Er23 and FruR, we will 
then turn our attention to making mutations in Er23 to eventually flip the folding from 
Er23 to FruR. Our first intuition is to start replacing the cysteine residues selected in Er23 
to an already successful disulfide bond replacement of Ala/Val or Val/Ala. This is 
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because the Er23 contains disulfide bonds within its structure while FruR has no disulfide 
bonds making this the main difference between the two protein structures. 
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Chapter 3 
Materials and Methods 
 
3.1 Synthesis of WT FruR and Trp Mutants 
Gene Construction 
 Methods of overlap PCR were used for reassembly, and the reactions were 
performed on a Flexigene thermal cycler (Techne Inc). The WT FruR gene was 
synthesized from six oligonucleotides (shown in 3.1). The tryptophan variant genes of 
FruR were also synthesized using these six primers and specific primers containing the 
specific mutations (primers shown in table 3.2). The genes were synthesized using two 
separate PCR reactions, the first using the respective six primers, and the second using 
the forward and reverse primers. Amplification reactions were carried out in a total 
volume of 50 µL with an annealing temperature of 55 °C for 20 cycles using Pfu 
polymerase.  
FW 
Primer 
ATTATATACCATGGCGAAAATTTATATTTCCAGGGCAGTAGTGGCATGAAA
CTG 
Rev 
Primer 
ATTATAATGGATCCTTATCGCAGACCCGCCGCCAC 
Primer 
1 
GGCAGTAGTGGCATGAAACTGGATGAAATTGCACGCCTTGCTGGAGTGAG 
Primer 
2 
CGTTAATCACATAGCTAGCGGTGGTGCGGCTCACTCCAGCAAGGCGTGCA 
Primer 
3 
CACCGCTAGCTATGTGATTAACGGCAAAGCGAAACAGTACCGAGTGTCTG 
Primer 
4 
CAGCCATCACTTTTTCCACGGTTTTATCAGACACTCGGTACTGTTTCGC 
Primer 
5 
CCGTGGAAAAAGTGATGGCTGTGGTGAGAGAACATAACTATCATCC     
Primer 
6 
TCGCAGACCCGCCGCCACCGCATTTGGATGATAGTTATGTTCTCTCACC 
Table 3.1: Primers used to construct WT FruR 
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I6W-1 GGCAGTAGTGGCATGAAACTGGATGAATGGGCACGCCTTGCTGGAGTGAG 
I6W-2 CGTTAATCACATAGCTAGCGGTGGTGCGGCTCACTCCAGCAAGGCGTGCC 
V12W-
1 
GGCAGTAGTGGCATGAAACTGGATGAAATTGCACGCCTTGCTGGATGGAG 
V12W-
2 
CGTTAATCACATAGCTAGCGGTGGTGCGGCTCCATCCAGCAAGGCGTGCA 
V38W-
4 
CAGCCATCCATTTTTCCACGGTTTTATCAGACACTCGGTACTGTTTCGC 
V38W-
5 
CCGTGGAAAAATGGATGGCTGTGGTGAGAGAACATAACTATCATCC 
M39W-
4 
CAGCCCACACTTTTTCCACGGTTTTATCAGACACTCGGTACTGTTTCGC 
M39W-
5 
CCGTGGAAAAAGTGTGGGCTGTGGTGAGAGAACATAACTATCATCC 
A25W-
3 
CACCGCTAGCTATGTGATTAACGGCAAATGGAAACAGTACCGAGTGTCTG 
A25W-
4 
CAGCCATCACTTTTTCCACGGTTTTATCAGACACTCGGTACTGTTTCCA 
Y19W-
2 
CGTTAATCACCCAGCTAGCGGTGGTGCGGCTCACTCCAGCAAGGCGTGCA 
Y19W-
3 
CACCGCTAGCTGGGTGATTAACGGCAAAGCGAAACAGTACCGAGTGTCTG 
Y28W-
3 
CACCGCTAGCTATGTGATTAACGGCAAAGCGAAACAGTGGCGAGTGTCTG 
Y28W-
4 
CAGCCATCACTTTTTCCACGGTTTTATCAGACACTCGCCACTGTTTCGC 
Table 3.2: Primers used to construct FruR Trp variants 
 
Cloning 
 Each of these contained an NcoI and BamHI restriction site used for digestion at 
37 °C for 2 hours. These inserts were then ligated with pHLIC vector (constructed by 
Venuka Durani, Brandon Sullivan and Thomas Magliery)21 which was also digested 
using NcoI and BamHI sites at 37 °C for 2 hours in a total volume of 50 µL. These 
digested vectors were then combined with the insert in a ligation reaction in a total 
volume of 10 µL which took place overnight at 16 °C. The now complete plasmid now 
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containing the gene insert was transformed into electrocompetent DH10B cells which 
were plated on LB agar containing 50 µg/µL ampicillin and were incubated at 37 °C 
overnight. Colonies were then picked and the DNA was extracted using Qiagen miniprep 
protocol. The DNA was then sequenced by Genewiz. 
 
Figure 3.1: FruR cloning vector 
 
Expression and Protein Purification 
 FruR WT and variants were then transformed into electrocompetant DE3 BL21 
cells which were then plated on LB agar containing 50 µg/µL ampicillin resistant 
antibiotics and were incubated at 37 °C overnight. 1L cultures were grown at 30 °C in 
2YT media for 4 hours or until reaching OD600=0.8. The cultures were then induced with 
0.1 mM IPTG during the log growth phase and expression occurred for another 6 hours at 
37 °C.  The cells were then centrifuged and resuspended in 15 mL of lysis buffer (50 mM 
Tris-HCl, 300 mM NaCl, 10 mM imidazole, pH 8). The cells were then lysed by 
emulsification. The cell lysate was then extracted from the pellet through centrifugation 
and was then mixed with 1 mL Ni-NTA slurry for one hour at 4 °C. The mixture was 
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poured through a pre-fritted column, and the flow-through was allowed to go to waste. 
The protein was then washed with 12 mL of wash buffer (50 mM Tris-HCl, 300 mM 
NaCl, 20 mM imidazole, pH 8) and eluted with 1.5 mL of elution buffer (50 mM Tris-
HCl, 300 mM NaCl, 250 mM imidazole, pH 8). Then 1.5 mL of CD buffer (50 mM 
sodium phosphate, 300 mM NaCl, pH 7.2) was added to dilute the protein solution. TEV 
protease (0.5 mg) was added twice along with 14 µL DTT and allowed to incubate at 
room temperature overnight. The solution was desalted with PD-10 columns (GE 
Amersham) into CD buffer (50 mM sodium phosphate, 300 mM NaCl, pH 7.2) and 
mixed with 1 mL Ni-NTA slurry (Qiagen) at 4 °C for a minimum of one hour. The 
solution was added to a pre-fritted column again and cleaved protein was collected. 
Protein was then concentrated using an Amicon Ultra-4 Centrifugal filter (Millipore) for 
future characterization. 
 
CD Spectroscopy 
 Both variants and WT FruR were analyzed on a Jasco J-185 CD Spectrometer at 
50 M concentrations, determined by UV absorption at 280 nm. Wavelength scans of the 
variants and WT were taken from 190-260 nm. Thermal denaturation scans were also 
taken, measuring 1 °C/min from 25-90 °C at 222 nm. Scans were acquired by Eva Petrik. 
 
Fluorimetry 
 WT FruR and Trp variant fluorescence were measured at 100 µM using an Olis 
DM45 fluorimeter. Samples were excited at 295 nm and data was analyzed using Olis 
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Spectral Works Software. The data was collected using absorbance scans from 310-410 
nm taken by Dr. Eva Petrik. 
M5 Experiment 
  Protein analysis was done using small volumes of protein (20 µL) in a 384 well 
plate. Data was collected usisng absorbance scans from 300-400 nm taken by Dr. Eva 
Petrik. 
 
3.2: Synthesis of WT Er23 and Cys-free variants 
Gene Construction 
Methods of overlap PCR were used for reassembly, and the reactions were 
performed on a Flexigene thermal cycler (Techne Inc). The WT Er23 gene was 
synthesized four primers (shown in Table 3.3). Variant genes were synthesized using four 
new primers containing their specific mutations which contain the positions replaced with 
either alanine or valine (primers shown in table 3.4). The genes were synthesized using 
two separate reactions, the first, a Klenow reaction using the respective two primers, and 
the second, a PCR reaction using the forward and reverse primers. Amplification 
reactions were carried out in a total volume of 50 µL at an annealing temperature of 55 
°C for 20 cycles using Pfu polymerase. Each of these contained an NcoI and BamHI 
restriction site used for digestion at 37 °C for 2 hours.  
Er23 
WT 
1 
GGCGAATGCGAACAGTGCTTTAGCGATGGCGGCGATTGCACGACCTG
CTTCAATAATGGCACCGGCCCATGCGCGAATTGCCTGGCGGGCTATCC
GGCGGGG 
Er23 
WT 
2 
GCAACCTCCATAGCACTGGCTCAGAAACGCGGTACAGTCGCTATTGCT
GCACCCCGCCGGATAGCCCGCCAGGCAATTCGCGCATGGGCCGGTGC
C 
Er23 
FW 
ATATATGGTACCGGCGAATGCGAACAGTGC 
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Er23 
Rev 
AATATACTCGAGTTAGCAACCTCCATAGCACTG 
Table 3.3: Primers for synthesis WT Er23 
Er23 
AV 6-
16 1 
GGCGAATGCGAACAGGCGTTTAGCGATGGCGGCGATTGCACGACC
GTGTTCAATAATGGCACCGGCCCATGCGCGAATTGCCTGGCGGGCT
ATCCGGCGG 
Er23 
VA 6-
16 1 
GGCGAATGCGAACAGGTGTTTAGCGATGGCGGCGATTGCACGACCG
CGTTCAATAATGGCACCGGCCCATGCGCGAATTGCCTGGCGGGCTA
TCCGGCGG 
Er23 6-
16 2 
GCAACCACCGTAGCATTGACTCAAAAAAGCGGTACAGTCAGAATTG
CTGCAGCCCGCCGGATAGCCCGCCAGGCAATTCGCGCATGGGCC 
Er23 6-
16 FW 
ATTATATACCATGGCGAAAATTTATATGGCGAATGCGAACAG 
Er23 6-
16 Rev 
ATTATAATGGATCCTTAGCAACCACCGTAGCATTG 
Er23 3-
24 AV 
1 
GGCGAAGCTGAACAGTGCTTTAGCGATGGCGGCGATTGCACGACCT
GCTTCAATAATGGCACCGGCCCAGTGGCGAATTGCCTGGCGGGCTA
TCCGGCGG 
Er23 3-
24 AV 
2 
GCAACCTCCATAGCACTGGCTCAGAAAAGCGGTACAGTCACTATTG
CTGCACCCCGCCGGATAGCCCGCCAGGCAATTCGCCACTGGGCCGG
TGCC 
Er23 3-
24 AV 
FW 
ATTATATACCATGGCGAAAATTTATATTTCCAGGGCGAAGCTGAAC
AG 
Er23 3-
24 VA 
1 
GGCGAAGTTGAACAGTGCTTTAGCGATGGCGGCGATTGCACGACCT
GCTTCAATAATGGCACCGGCCCAGCGGCGAATTGCCTGGCGGGCTA
TCCGGCGG 
Er23 3-
24 VA 
2 
GCAACCTCCATAGCACTGGCTCAGAAAAGCGGTACAGTCACTATTG
CTGCACCCCGCCGGATAGCCCGCCAGGCAATTCGCCGCTGGGCCGG
TGCC 
Er23 3-
24 VA 
FW 
ATTATATACCATGGCGAAAATTTATATTTCCAGGGCGAAGTTGAAC
AG 
Er23 3-
24 Rev 
ATTATAATGGATCCTTAGCAACCTCCATAGCACTG 
Table 3.4: Primers for synthesis Er23 Cys-free variants 
Cloning 
 The cloning of these Er23 WT and Cys-free variants were completed using the 
same protocol as FruR. We also constructed a pHLIC-preMBP plasmid for cloning to 
afford periplasmic expression.  
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Figure 3.2: Vector maps for WT Er23 cloning 
Protein Expression and Purification 
 Er23 WT and variants were expressed by the same protocol as FruR. However 
WT Er23 was previously cloned into Origami B: F-ompT hsdSB(rB
- mB
-) gal dcm lacY1 
ahpC (DE3) gor522: Tn10 trxB pLysS (CamR, KanR, TetR) from EMD. Once induced 
during the log growth phase, the expression occurred overnight at 37 °C.  The protein 
was then purified by the same method as FruR described above except the solution was 
desalted and imidazole removed by dialysis into CD buffer (50 mM sodium phosphate, 
300 mM NaCl, pH 7.2). Protein was then concentrated using an Amicon Ultra-4 
Centrifugal filter (Millipore) for future characterization. 
CD Spectroscopy 
 Both variants and WT Er23 were analyzed on a Jasco J-185 CD Spectrometer. 
Further protein stability studies were conducted by 7 M Guanidine and 9 M Urea melts at 
various concentrations with and without the addition of the disulfide bond reducer TCEP. 
Scans were taken by Eva Petrik. 
HSQC-NMR 
 Each variant was synthesized using the previously mentioned protocol, but in 
minimal media (0.5 M Na citrate, trace metal solution, 1 M MgSO4, 40% Glucose, 10 
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mg/ml thiamine, dH2O) instead of rich 2YT. 
15N-labeled NH4Cl was used as the nitrogen 
source, and variants were exchanged into CD buffer by dialysis. Samples were 
concentrated to 1 mg/mL and mixed with 10% D2O directly before experiments were 
conducted. The 1H, 15N-HSQC spectra was obtained from a 600 MHz Bruker NMR with 
inverse probe using standard Lewis E. Kay pulse sequences at 25 C. The actual scans 
were acquired by Dr. Chunhua Yuan. 
Crystallography 
 Er23 Cys-free variants crystals were obtained from sitting drop trays at 9 °C with 
a 1:1 protein to mother liquor ratio. Protein samples were dialyzed into CD buffer and 10 
mM HEPES buffer. 
Ellman Reaction Experiment 
 DTNB stock solution (19 mL KPO4, 159.4 mg DTNB, 60 mg Sodium 
Bicarbonate, pH 7) was prepared along with 1M Tris (pH 8). The DTNB working reagent 
was prepared by adding 50 µL DTNB solution, 100 µL Tris solution, and 840 µL water 
with the final volume equaling 1000 µL with a 10 µL sample. The solution was mixed 
and cuvette was placed into UV spectrophotometer and a background scan was taken 
using the solution as the background. 10 µL of the sample solution was added to 990 µL 
of DTNB reagent. The solution was mixed well and incubated at room temperature for 5 
min. The optical absorbance was then measured at 595 nm. The molarity of (-SH) groups 
was calculated by finding the absorbance and dividing by 13600 M-1cm-1 (extinction 
coefficient of reagent). 
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Chapter 4 
Results 
 
4.1: Synthesis and Characterization of FruR Trp Variant 
When deciding on what mutations to make to the WT FruR protein, we consulted 
with previous work done by Venuka Durani25 and Eva Petrik. They had previously done 
a complete alanine scan of the entire sequence of FruR. This alanine scan would allow us 
to deduce which specific amino acids were absolutely necessary for the specific folding 
of FruR. Those residues which were important were not chosen to mutate. We then also 
consulted the LacI-GalR family of proteins from which FruR is a part of. We looked at 
those sequences which were similar to FruR, but which had a tryptophan variant 
integrated within the sequence. These residues which seem to be buried in the 
hydrophobic core of the protein; 39W and 25W were chosen based on this family 
sequence alignment and showed us where Trp can be found in other members of this LacI 
family. 
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Figure 4.1: LacI-GalR pfam alignment for FruR with arrows indicating 
sequences which contain a Trp (Petrik) 
We also needed this Trp residue to be buried within the hydrophobic core of the 
protein, when folded, and exposed to the solution, when unfolded. This addition will 
allow us to observe the folded and unfolded states via fluorescence. This goal we knew 
would be very difficult to achieve due the small size of FruR and because it has a very 
small core. Trp is a relatively large residue so integrating it within FruR will be a 
challenge. Y19W and Y28W were chosen because they each contained tyrosine which is 
a large hydrophobic residue similar to tyrosine. We also picked these positions because 
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they contribute to the stabilization of the molecule due to stacking of the aromatic rings 
and formation of hydrogen bonds between them6. This is shown in Figure 4.2 below. 
Based on the alanine scan, these specific mutations were chosen: 12W, 38W, and 6W 
which showed the residues within FruR are especially important towards the specific 
folding of WT FruR. We also created these mutations virtually in Yasara24 and tested 
them using FoldX24 to see if any steric clashes would occur. 
 
Figure 4.2: Shows stability by stacking and H-bonds between Tyr19 and Tyr28 of 
WT FruR 6. 
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Figure 4.3: Before melt CD scan of WT FruR and Trp variants at 25°C 
 
Figure 4.4: Thermal Melt Scan of WT FruR and variants 
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Figure 4.5: After melt CD scan taken at 25 °C to see if folding is reversible 
 
These CD scan results show which specific mutants fold like WT FruR which is 
predominantly alpha helical with significant peaks at 208 nm and 222 nm. V38W, Y28W, 
and A25W all were shown to fold like WT, while I6W, Y19W, and M39W were 
unfolded or molten globule. So, we continued our studies with V38W, Y28W, and 
A25W. Our next step was to do a thermal melt via CD machine in order to analyze the 
stability of these mutations in comparison to WT FruR where we heat up the protein 
samples to a maximum of 90 °C. We then fit the data to a Gaussian curve in order to 
observe the melting temperatures more easily. These data are shown above in Figure 4.4, 
which displays the mutant’s stability by melting temperature in comparison to WT FruR. 
We then took another CD scan of the protein after cooling back down to 25 °C shown in 
Figure 4.5. 
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Figure 4.6: Fluorescence of folded and unfolded Trp variants  
These results are particularly interesting because one of the variants, A25W, is shown 
to be more thermodynamically stable than that of the WT structure. This is quite 
surprising considering that this variant includes the addition of a large tryptophan residue 
within FruR’s very small hydrophobic core. We can now measure the fluorescence of 
these variants and conclude whether we have indeed obtained a successful fluorescent 
mutant. This data are shown in Figure 4.6 above. 
Table 4.1 below shows that all the Trp mutants are less stable than WT except for 
A25W. A25W turned out to be more stabilizing than WT by 5 °C. These data show that 
we indeed introduced a fluorescent residue within the hydrophobic core of the molecule. 
We took a scan of both the folded protein in CD buffer and the unfolded protein with the 
addition 8 M Urea, where the protein is unfolded. 
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These fluorimeter results show that I6W and Y28W either are already unfolded prior 
to the addition of 8 M urea or the Trp residue is displayed on the surface of the protein 
and not within the hydrophobic core of the molecule, therefore making it impossible to 
tell the difference between the folded and unfolded states. Together with the CD data 
indicates that these variants were unfolded. However, A25W (folded shown in red and 
unfolded shown in purple) successfully has its Trp residue buried within the hydrophobic 
core of the molecule, showing a broad peak between 330 nm and 360 nm. The unfolded 
A25W variant shows a higher intensity of fluorescence due to the Trp being exposed and 
has a significant peak at 360 nm. This will make further characterization of the 
intermediate variants when flipping the fold from FruR to Er23 much easier to visualize 
and characterize in future experiments. High throughput methods can now be used to 
analyze FruR and intermediate variants by using 96 or 384 well plates for analysis using 
small volumes (10-20 µL) of the protein (Figure 4.7). 
 
Table 4.1: Summary of Trp variants made and what information was collected from 
each (MG stands for molten globule) 
 
 
Variannt PCR Seq Expr scan Tm NaPi 8Murea
I6W     MG 355 360
A25W     60 ~345 360
Y28W     44.5 360 360
V38W     46.5 360 360
M39W     MG
FluorescenceCD
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Figure 4.7: HTTS: 384 well plate urea melt of FruR A25W variant 
 
Figure 4.8: A25W graphed analysis of the shift in the peak with change in urea 
concentration. 
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Figure 4.8 above is a fluorescence scan of a urea melt of the successful A25W variant of 
FruR to see if expression could be scaled down to 20 µL while still getting a strong 
enough signal. This data proves that high-throughput methods can indeed be used in 
future characterization of this protein. The graph below this shows how the fluorescent 
peak changes with increasing urea concentration. As the protein unfolds the peak shifts to 
a higher wavelength signifying that the fluorescent Trp residue is becoming more 
exposed to solvent thus making the intensity of fluorescence increase. This data was 
collected by Dr. Eva Petrik. 
 
4.2: Synthesis and Characterization of WT Er23 
When we set out to express WT Er23 we knew it would be difficult due to the large 
number of disulfide bonds within the structure of the molecule. Er23 contains 10 cysteine 
residues which make 5 disulfide bridges within the protein.  Because we knew these Cys 
residues would make this protein particularly difficult to express and purify we decided 
to consider two ways in which we could express this protein: by periplasmic and 
cytoplasmic expression methods. Cytoplasmic expression is the usual way in which 
proteins in the Magliery lab are expressed and it is also the method by which FruR was 
expressed. Periplasmic expression is used mainly for proteins like Er23 with multiple 
disulfide bonds. This expression method is useful because it helps to fold the disulfide 
bonds by creating an oxidizing environment, also contains two foldases, DsbA and DsbC, 
which catalyze formation and isomerization of disulfide bonds 22.  
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Figure 4.9: WT Er23 with all disulfide bonds shown in red. Made using Foldx24 
Although we had these methods planned, we had Er23 already cloned into Origami B 
cells by Venuka Durani25 and had successfully expressed using cytoplasmic method. So, 
we used this method for further expression of Er23. In addition to using regular methods 
of expression we also wanted to see if we could express this protein using minimal media 
in order to obtain an NMR scan of Er23. 
 
Figure 4.10: SDS-Page gel showing expression of Er23 by regular and minimal 
media 
Expected 
location 
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Once expressed we wanted to characterize this protein by many methods including 
NMR, mass spec, CD, and guanidine melts, crystallography, etc. The 1H NMR spectrum 
below shows well dispersed peaks signifying a well folded protein structure. 
 
Figure 4.11: Proton NMR of WT Er23 
The mass spectrum shown below shows the expected mass for Er23 which once again 
signifies that we do have the correct WT Er23 structure. 
 
Figure 4.12: Mass Spectrometry of Er23 (mass is 5104 Da) 
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We first wanted to conduct an Ellman Reaction in order to see if the disulfide 
bonds within the molecule were folded correctly within the structure. Only with the 
addition of a reducing agent, TCEP, would we be able to see a change in color of the 
sample to yellow, indicating the existence of free thiols. Only samples which contained 
TCEP turned yellow with addition of Ellman Reagent. When subtracting the background 
from the samples, there was a negligible difference even with addition of reducing agent 
there are still no free thiols being exposed. This concluded that the disulfide bonds within 
Er23 were indeed folded. 
The CD spectra results below show a significant peak at 209 nm for WT Er23 which 
is expected for a protein which has disulfide bonds and alpha-helices23. After heating the 
molecule up and doing a thermal melt another scan was taken. There were no differences 
between the scans taken before and after the stability melt which signifies a very stable 
protein. This we hypothesized was due to the tightly packed core of Er23 and many 
disulfide bridges present within its structure. 
 
Figure 4.13: CD spectra of WT Er23 before melt and after melt scans taken to see 
is folding is reversible 
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This thermal melt data tracks the signal 222 nm while the molecule is heated up to 95 °C. 
If there was a difference in the structure while heating, the signal would either increase or 
decrease and this data shows no structural change because the data doesn’t change from 
the scan taken before the melt to the scan taken after the melt was completed. This 
signifies a very stable molecule. 
 
Figure 4.14: Thermal melt CD spectra of WT Er23 
This CD data shows the extreme stability of WT Er23. Even when heating this 
protein to temperatures of 95 °C, the structure remains intact. This is shown in the 
thermal melt scan and shown in the CD scan above where the before and after melt scans 
look identical to one another. Because this data was so interesting we decided to take a 
closer look at the structure and stability of Er23 and to gain more information about 
disulfide bonds and how they contribute to stabilization and folding. In order to get a 
better understanding of how this protein folds and how stable the molecule is we decided 
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to conduct a urea melt of the protein by adding urea (9 M) with and without the addition 
of TCEP, a disulfide bond reducer to see if this would unfold the protein. The before melt 
scan shows that the protein is still relatively folded even with the addition of urea and 
TCEP shown in Figure 4.15 below. 
 
Figure 4.15: Before melt CD scans of Er23 with and without the addition of Urea 
and TCEP 
These thermal melt scans shown below in Figure 4.16 depict that there is no 
significant change in the case of only adding urea to the protein. Only with the addition 
of TCEP and urea, the disulfide bond reducer, does the structure of the molecule begin to 
break apart and unfold. With the addition of only TCEP to the samples the structure does 
begin to unfold while heating shown in the gray and light blue data and is completely 
unfolded during the reverse scan shown in pink and gold. 
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Figure 4.16: Thermal melt scans of urea melt 
 
Figure 4.17: After melt CD scans of Er23 with and without the addition of urea 
and TCEP 
This CD data taken after cooling the protein down to 25 °C, shows that in order to 
completely unfold Er23 you must add a disulfide bond reducer, such as TCEP, to 
break the disulfide bonds and degrade the protein by adding a denaturation agent such 
as urea and heat it up to unfold the structure completely. 
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 Because Er23 was not unfolding completely with the addition of 8 M urea, we 
decided to conduct some more stability experiments of Er23 by using a different 
denaturation agent, guanidine also with and without the addition of TCEP by adding 
different concentrations of guanidine (from 0 M-5 M) and taking scans over 3 days. The 
data below in Figures 4.18 and 4.19 shows that after the initial addition of guanidine with 
and without TCEP, Er23 remains folded. Some of the data points are not shown due to an 
increase Dynovoltage over 600 V. 
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Figure 4.18 and 4.19: Day 1 CD scans of Er23 from 0 M to 5 M guanidine with and 
without addition of TCEP 
 After a 24 hour incubation in guanidine, the protein still is shown to be relatively 
folded shown in Figure 4.20. However, the samples which were incubated with the 
addition of TCEP, are beginning to unfold shown in Figure 4.21. 
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Figure 4.20 and 4.21: 24 hr incubation CD scans of Er23 from 0 M to 5 M Guanidine 
with and without addition of TCEP 
Finally after 48 hour incubation in Guanidine with the addition of TCEP, the protein was 
shown to be completely unfolded. However, with only the addition of Guanidine, the 
protein is still remaining completely folded after 48 hours shown in Figure 4.22. 
 
Figure 4.22: 48 hr incubation CD scans of Er23 from 0 M to 5 M Guanidine 
 The first and second day data show that not much unfolding has occurred with the 
addition of guanidine. After the third day, Er23 was completely unfolded with the 
addition of TCEP; however, with just the addition of guanidine had no effect on the 
structure of Er23. 
We also wanted to set up a series of crystallography conditions to try and obtain a 
crystal structure of Er23. So far, we have gotten some promising results from these 
specific conditions. 
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Figure 4.23: Crystallography of Er23 1. 0.1 M Tris, 3.4 M 1,6 hexanediol, 0.2 M 
magnesium chloride; 2. O.1 M bicine pH 9, 2 M magnesium chloride; 3.  0.1 M 
Sodium Acetate , pH  4.6, 20%,  Isopropanol, 0.2 M calcium chloride; 4. 0.1 M TRIS, 
pH 8.5, 30% Isopropanol, 0.2 M Ammonium Acetate 
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3. 
4. 
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Figure 4.24: HSQC of WT Er23 
Lastly, we decided to obtain an HSQC NMR of Er23 in order to give us a better 
idea of what the structure looks like. This HSQC data shows us not only that WT Er23 is 
definitely folded, but also will allow us to solve the structure of Er23 and compare this 
with the Cys-free variants in the future. We can deduce that the structure is folded 
because there are about 50 cross-peaks which are well defined and sharp. 
4.3 Synthesis and Characterization of Er23 Cys-free variants 
 When deciding which mutations to make to WT Er23 we knew that we wanted to 
start by individually taking out each disulfide bond and replacing them with Ala-Val and 
Val-Ala mutations which has been shown to work with Rop protein within the Magliery 
lab18. This is because not only did we want to begin the flipping fold experiment, but 
another goal of ours was to see the stability effects of disulfide bonds on Er23. Also, the 
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main difference between FruR and Er23 is the addition of disulfide bonds within the 
structure of Er23 and lacking in the structure of FruR. In order to predict the destabilizing 
effects of these mutations we made them computationally within FoldX24 and used this 
program to measure the stability by ΔΔG. Those variants which had the smallest ΔΔG 
were the variants which were most similar to WT Er23 in stability. 
ΔΔG Ala-Val Val-Ala 
Cys 35&51 3.14 2.93 
Cys 13&47 3.92 2.5 
Cys 3&24 5.52 1.79 
Cys 27&40 2.55 4.45 
Cys 6&16 0.6 2.57 
 
Table 4.2: shows the ΔΔG’s of the specific Cys-free mutants analyzed by Foldx24. 
Based on the ΔΔG data we collected, we decided to move forward and mutate the 
disulfide bonds with cysteine residues at 6&16 and 3&24. We wanted to try to replace 
them with both Ala-Val and Val-Ala mutations and analyze the stability effects of these 
mutations in comparison to WT. Once sequences for variants 1: 6&16 Ala-Val, 2: 6&16 
Val-Ala, 3: 3&24 Ala-Val were confirmed we expressed and purified them.  
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Figure 4.25: SDS-Page purification gel showing Tev reaction of variants 1, 2, and 3 
(Petrik) 
 As shown in Figure 4.25 above, the expression of both variants of 6&16 Ala-Val 
and Val-Ala were successful. However, variant 6&16 Ala-Val expression failed. This 
was possibly due to the mutation of the disulfide bond at this position. This specific 
disulfide bond may be needed in order for Er23 to fold correctly and successfully 
express.  
 Soon, we also got the last variant 3&24 Val-Ala sequence confirmed and 
expressed this along with a second attempt at expression of the 3&24 Ala-Val variant. 
This second attempt and first attempt at expression of these variants also failed. This 
further led us to the conclusion that the removal of this disulfide bond is detrimental to 
the folding of Er23 and caused the protein to unfold. 
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Chapter 5 
Discussion and Future Work 
 A successful variant of FruR has been synthesized and purified containing an 
introduction of a Trp residue within the hydrophobic core of the protein. This variant will 
make further characterization of mutants for the flipping fold experiment easier due to the 
use of high throughput methods. 
 Wild type Er23 has been successfully expressed and has been shown to be folded 
and to have disulfide bonds within its structure correctly formed. Further characterization 
of this protein is to be conducted in the future including the production of a solved crystal 
structure.  
 Synthesis of the first four Cys-free variants has been conducted and 
characterization of these mutants is to be done in the future. It has been shown that 
variants 6&16 Ala-Val, 6&16 Val-Ala, and 3&24 Ala-Val all successfully express. 
Whereas, variant 3&24 Val-Ala does not successfully express. This could be due to the 
removal of a crucial disulfide bond for the correct folding of Er23. These mutants will be 
initial studies towards the flipping of Er23 into FruR. They will also give insight into the 
stabilizing effects of removing disulfide bonds. 
Future work includes further characterization of wild-type Er23 as well as 
expression and characterization of Er23 Cys-free variants. Another possible direction for 
the flipping fold experiment could be to introduce disulfide bonds into the structure of 
FruR and see the effects of these mutations on the structure. 
46 
 
References: 
1. Anfinsen, C. B., “The formation and stabilization of protein structure.”Biochem. 
J. 1972, 128, (4), 737-749. 
2. Bryan, P. & Orban, J. “Proteins that Switch Folds,” CurrOpinStructBiol, 2010, 
482–488. 
3. Cao, Baoqiang and Elber, R., “Computational exploration of the network of 
sequence flow between protein structures,” 2010, 78(4): 985–1003. 
4. DALAL, S. and REGAN, R., “Understanding the sequence determinants of 
conformational switching using protein design,” Protein Science 2000, 9:1651–
1659. 
5. Saier, M. H. & Ramseier, T. M. (1996). “The catabolite repressor/activator (Cra) 
protein of enteric bacteria.”Journal of Bacteriology 178, 3411-3417. 
6. Penin, F., Geourjon, C., Montserret, R., Bockmann, A., Lesage, A., Yang, Y. S., 
BonodBidaud, C., Cortay, J. C., Negre, D., Cozzone, A. J. & Deleage, G. (1997). 
“Three-dimensional structure of the DNA-binding domain of the fructose 
repressor from Escherichia coli by H-1 and N-15 NMR.”Journal of Molecular 
Biology 270, 496-510. 
7. Max Chavarría, César Santiago, Raúl Platero, TinoKrell, José M. Casasnovas, 
Víctor de Lorenzo, “Fructose 1-Phosphate Is the Preferred Effector of the 
Metabolic Regulator Cra of Pseudomonasputida,” J Biol Chem. 2011 March 
18; 286(11): 9351–9359. 
47 
 
8. Sarkar, D., Siddiquee, K. A. Z., Arauzo-Bravo, M. J., Oba, T. & Shimizu, K. 
(2008). “Effect of cra gene knockout together with edd and iclR genes knockout 
on the metabolism in Escherichia coli.”Archives of Microbiology 190, 559-571. 
9. Scarabel, M., Penin, F., Bonodbidaud, C., Negre, D., Cozzone, A. J. & Cortay, J. 
C. (1995). “Overproduction, purification and structural characterization of the 
functional N-terminal DNA-binding domain of the fru repressor from 
Escherechia coli K-12.”Gene 153, 9-15. 
10. Giuseppe Graziano Di, Cristina Miceli, Ralph Zahn, Fred Damberger, Kurt 
Wüthrich, Pierangelo Luporini, “A structurally deviant member of the 
Euplotesraikovi pheromone family: Er23,” J Eukaryot Microbiol. 2002 Jan-
Feb; 49(1): 86–92. 
11. R. Zahn, F. Damberger, C. Ortenzi, P. Luporini, K. Wüthrich “NMR structure of 
the Euplotesraikovi pheromone Er23 and identification of its five disulfide 
bonds.” J Mol Biol. 2001 November 9; 313(5): 923–931 
12. Adriana Vallesi, PatriziaBallarini, Barbara Di Pretoro, Claudio Alimenti, Cristina 
Miceli, Pierangelo Luporini, “Autocrine, mitogenic pheromone receptor loop of 
the ciliate Euplotesraikovi: pheromone-induced receptor internalization. Eukaryot 
Cell.” 2005 July; 4(7): 1221–1227. 
13. A. Concetti, S. Raffioni, C. Miceli, D. Barra, P. Luporini, “Purification to 
apparent homogeneity of the mating pheromone of mat-1 homozygous 
Euplotesraikovi.”J Biol Chem. 1986 August 15; 261(23): 10582–10586. 
48 
 
14. Paul H. Bessette, Fredrik Åslund, Jon Beckwith, and George Georgiou, “Efficient 
folding of proteins with multiple disulfide bonds in the Escherichia 
coli cytoplasm” PNAS 1999 96 (24) 13703-13708 
15. Michael Reinwarth, Bernhard Glotzbach, Michael Tomaszowski, Sebastian 
Fabritz, Olga Avrutina, Harald Kolmar, “Oxidative folding of peptides with 
cystine-knot architectures: kinetic studies and optimization of folding conditions.” 
Chembiochem. 2013 January 2; 14(1): 137–146. 
16. T. A. Klink, K. J. Woycechowsky, K. M. Taylor, R. T. Raines, “Contribution of 
disulfide bonds to the conformational stability and catalytic activity of 
ribonuclease A.”Eur J Biochem. 2000 January; 267(2): 566–572. 
17. Magliery, T.J.; Lavinder, J.J. & Sullivan, B.J. "Protein stability by number: high-
throughput and statistical approaches to one of protein science's most difficult 
problems," Curr. Opin. Chem. Biol. 2011, 15: 443-451. 
18. Sanjay B Hari, Chang Byeon, Jason J Lavinder, Thomas J Magliery “Cysteine-
free Rop: A four-helix bundle core mutant has wild-type stability and structure 
but dramatically different unfolding kinetics.” Protein Science 2010, 19, 670-679. 
19. Durani, V. &Magliery, T.J. "Protein Engineering and Stabilization from Sequence 
Statistics: Variation and Co-Variation Analysis," Meth. Enzymol., 2010, 523: 237-
256. 
20. R Zwanzig, A Szabo, B Bagchi “Leventhal’s Pardox,” Proc Natl Acad Sci U S 
A. 1992 January 1; 89(1): 20–22. PMCID: PMC48166. 
49 
 
21. Durani, V.; Sullivan, B.J. & Magliery, T.J. (2012) "Simplifying protein 
expression with ligation-free, traceless and tag-switching plasmids," Protein Expr. 
Purif., 85: 9-17 
22. Urban A, Leipelt M, Eggert T, Jaeger KE. 2001. “DsbA and DsbC affect 
extracellular enzyme formation in Pseudomonas aeruginosa.” J. Bacteriol. 
183:587–596. 
23. Nilesh Ranjan Maiti and Witold K. Surewicz. “The Role of Disulfide Bridge in 
the Folding and Stability of the Recombinant Human Prion Protein.” Biol. 
Chem. 2001 276: 2427-2431. First Published on November 7, 2000, JBC: 276:24  
24. Van Durme J, Delgado J, Stricher F, Serrano L, Schymkowitz J and Rousseau F. 
“A graphical interface for the FoldX forcefield.” Bioinformatics. 2011 Jun 15; 
27(12):1711-2.27-2431. 
25. Durani, Venuka. “The Cycle of Protein Engineering: Bioinformatics Design of 
Two Dimeric Proteins and Computational Design of a Small Globular Domain.” 
2012: OSU Graduate Program in Chemistry Thesis work. 
26. Marijke Hospes,   Johnny Hendriks and Klaas J. Hellingwerf 
“Tryptophan fluorescence as a reporter for structural changes in photoactive 
yellow protein elicited by photo-activation.”Photochem. Photobiol. Sci., 2013,12, 
479-488. 
 
 
